Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda

Joseph Kagaayi, Michele L. Dreyfuss, Godfrey Kigozi, Michael Z. Chen, Fred Wabwire-Mangen, David Serwadda, Maria J Wawer, Nelson K. Sewankambo, Fred Nalugoda, Noah Kiwanuka, Meddie Kiddugavu, Ronald H Gray

Research output: Contribution to journalArticle

Abstract

To assess the effectiveness of maternal self-administration of nevirapine for prevention of mother-to-child transmission (MTCT) of HIV, we conducted a program to provide maternal and newborn doses of nevirapine to pregnant women in rural Uganda. Women provided blood for HIV testing and were offered voluntary counseling and testing (VCT) during annual community HIV surveys. HIV-positive women who accepted VCT were offered nevirapine tablets and syrup. Blood samples were collected posrpartum from women and their babies. Infants were tested for HIV by polymerase chain reaction (PCR), and a subsample of maternal and infant blood was assayed for nevirapine. Among the 981 women tested for HIV, 900 (91.7%) accepted VCT, of whom 105 (11.7%) were HIV-positive. Ninety-three women accepted nevirapine, of whom 81 (87.1%) were followed posrpartum; 75 (92.6%) reported receipt of the drug, and 69 reported taking the tablets (85.2%). There were 81 liveborn babies (3 sets of twins), and 67 (84.8%) received the syrup. In a subsample of 25 mothers reporting receipt of the drug, nevirapine was detected in 22 (88.0%) and 24 (96.0%) babies tested. PCR of 67 infant blood samples identified 5 HIV-positive (MTCT rate = 7.5%, 95% confidence interval [CI]: 0.3%-16.6%). Mothers can administer nevirapine to themselves and their newborns and can achieve low rates of perinatal HIV infection.

Original languageEnglish (US)
Pages (from-to)121-124
Number of pages4
JournalJournal of Acquired Immune Deficiency Syndromes
Volume39
Issue number1
DOIs
StatePublished - May 1 2005

Fingerprint

Nevirapine
Self Medication
Uganda
Mothers
HIV
Newborn Infant
Counseling
Tablets
Polymerase Chain Reaction
Self Administration
Pharmaceutical Preparations
HIV Infections
Pregnant Women
Confidence Intervals

Keywords

  • HIV/AIDS
  • Mother-to-child HIV transmission
  • Nevirapine
  • Uganda
  • Voluntary counseling and testing

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this

Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda. / Kagaayi, Joseph; Dreyfuss, Michele L.; Kigozi, Godfrey; Chen, Michael Z.; Wabwire-Mangen, Fred; Serwadda, David; Wawer, Maria J; Sewankambo, Nelson K.; Nalugoda, Fred; Kiwanuka, Noah; Kiddugavu, Meddie; Gray, Ronald H.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 39, No. 1, 01.05.2005, p. 121-124.

Research output: Contribution to journalArticle

Kagaayi, J, Dreyfuss, ML, Kigozi, G, Chen, MZ, Wabwire-Mangen, F, Serwadda, D, Wawer, MJ, Sewankambo, NK, Nalugoda, F, Kiwanuka, N, Kiddugavu, M & Gray, RH 2005, 'Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda', Journal of Acquired Immune Deficiency Syndromes, vol. 39, no. 1, pp. 121-124. https://doi.org/10.1097/01.qai.0000148530.66587.7c
Kagaayi, Joseph ; Dreyfuss, Michele L. ; Kigozi, Godfrey ; Chen, Michael Z. ; Wabwire-Mangen, Fred ; Serwadda, David ; Wawer, Maria J ; Sewankambo, Nelson K. ; Nalugoda, Fred ; Kiwanuka, Noah ; Kiddugavu, Meddie ; Gray, Ronald H. / Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda. In: Journal of Acquired Immune Deficiency Syndromes. 2005 ; Vol. 39, No. 1. pp. 121-124.
@article{295ad2ef6fad4e269fec5c34782457a5,
title = "Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda",
abstract = "To assess the effectiveness of maternal self-administration of nevirapine for prevention of mother-to-child transmission (MTCT) of HIV, we conducted a program to provide maternal and newborn doses of nevirapine to pregnant women in rural Uganda. Women provided blood for HIV testing and were offered voluntary counseling and testing (VCT) during annual community HIV surveys. HIV-positive women who accepted VCT were offered nevirapine tablets and syrup. Blood samples were collected posrpartum from women and their babies. Infants were tested for HIV by polymerase chain reaction (PCR), and a subsample of maternal and infant blood was assayed for nevirapine. Among the 981 women tested for HIV, 900 (91.7{\%}) accepted VCT, of whom 105 (11.7{\%}) were HIV-positive. Ninety-three women accepted nevirapine, of whom 81 (87.1{\%}) were followed posrpartum; 75 (92.6{\%}) reported receipt of the drug, and 69 reported taking the tablets (85.2{\%}). There were 81 liveborn babies (3 sets of twins), and 67 (84.8{\%}) received the syrup. In a subsample of 25 mothers reporting receipt of the drug, nevirapine was detected in 22 (88.0{\%}) and 24 (96.0{\%}) babies tested. PCR of 67 infant blood samples identified 5 HIV-positive (MTCT rate = 7.5{\%}, 95{\%} confidence interval [CI]: 0.3{\%}-16.6{\%}). Mothers can administer nevirapine to themselves and their newborns and can achieve low rates of perinatal HIV infection.",
keywords = "HIV/AIDS, Mother-to-child HIV transmission, Nevirapine, Uganda, Voluntary counseling and testing",
author = "Joseph Kagaayi and Dreyfuss, {Michele L.} and Godfrey Kigozi and Chen, {Michael Z.} and Fred Wabwire-Mangen and David Serwadda and Wawer, {Maria J} and Sewankambo, {Nelson K.} and Fred Nalugoda and Noah Kiwanuka and Meddie Kiddugavu and Gray, {Ronald H}",
year = "2005",
month = "5",
day = "1",
doi = "10.1097/01.qai.0000148530.66587.7c",
language = "English (US)",
volume = "39",
pages = "121--124",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda

AU - Kagaayi, Joseph

AU - Dreyfuss, Michele L.

AU - Kigozi, Godfrey

AU - Chen, Michael Z.

AU - Wabwire-Mangen, Fred

AU - Serwadda, David

AU - Wawer, Maria J

AU - Sewankambo, Nelson K.

AU - Nalugoda, Fred

AU - Kiwanuka, Noah

AU - Kiddugavu, Meddie

AU - Gray, Ronald H

PY - 2005/5/1

Y1 - 2005/5/1

N2 - To assess the effectiveness of maternal self-administration of nevirapine for prevention of mother-to-child transmission (MTCT) of HIV, we conducted a program to provide maternal and newborn doses of nevirapine to pregnant women in rural Uganda. Women provided blood for HIV testing and were offered voluntary counseling and testing (VCT) during annual community HIV surveys. HIV-positive women who accepted VCT were offered nevirapine tablets and syrup. Blood samples were collected posrpartum from women and their babies. Infants were tested for HIV by polymerase chain reaction (PCR), and a subsample of maternal and infant blood was assayed for nevirapine. Among the 981 women tested for HIV, 900 (91.7%) accepted VCT, of whom 105 (11.7%) were HIV-positive. Ninety-three women accepted nevirapine, of whom 81 (87.1%) were followed posrpartum; 75 (92.6%) reported receipt of the drug, and 69 reported taking the tablets (85.2%). There were 81 liveborn babies (3 sets of twins), and 67 (84.8%) received the syrup. In a subsample of 25 mothers reporting receipt of the drug, nevirapine was detected in 22 (88.0%) and 24 (96.0%) babies tested. PCR of 67 infant blood samples identified 5 HIV-positive (MTCT rate = 7.5%, 95% confidence interval [CI]: 0.3%-16.6%). Mothers can administer nevirapine to themselves and their newborns and can achieve low rates of perinatal HIV infection.

AB - To assess the effectiveness of maternal self-administration of nevirapine for prevention of mother-to-child transmission (MTCT) of HIV, we conducted a program to provide maternal and newborn doses of nevirapine to pregnant women in rural Uganda. Women provided blood for HIV testing and were offered voluntary counseling and testing (VCT) during annual community HIV surveys. HIV-positive women who accepted VCT were offered nevirapine tablets and syrup. Blood samples were collected posrpartum from women and their babies. Infants were tested for HIV by polymerase chain reaction (PCR), and a subsample of maternal and infant blood was assayed for nevirapine. Among the 981 women tested for HIV, 900 (91.7%) accepted VCT, of whom 105 (11.7%) were HIV-positive. Ninety-three women accepted nevirapine, of whom 81 (87.1%) were followed posrpartum; 75 (92.6%) reported receipt of the drug, and 69 reported taking the tablets (85.2%). There were 81 liveborn babies (3 sets of twins), and 67 (84.8%) received the syrup. In a subsample of 25 mothers reporting receipt of the drug, nevirapine was detected in 22 (88.0%) and 24 (96.0%) babies tested. PCR of 67 infant blood samples identified 5 HIV-positive (MTCT rate = 7.5%, 95% confidence interval [CI]: 0.3%-16.6%). Mothers can administer nevirapine to themselves and their newborns and can achieve low rates of perinatal HIV infection.

KW - HIV/AIDS

KW - Mother-to-child HIV transmission

KW - Nevirapine

KW - Uganda

KW - Voluntary counseling and testing

UR - http://www.scopus.com/inward/record.url?scp=20944433789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20944433789&partnerID=8YFLogxK

U2 - 10.1097/01.qai.0000148530.66587.7c

DO - 10.1097/01.qai.0000148530.66587.7c

M3 - Article

C2 - 15851922

AN - SCOPUS:20944433789

VL - 39

SP - 121

EP - 124

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 1

ER -